Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2014 Jan 20;383(9914):284–286. doi: 10.1016/S0140-6736(13)62572-6

Responding to priority health challenges in the Arab world

Ala Alwan a
PMCID: PMC7134683  PMID: 24452039

The Arab world today faces major challenges to health development, which are captured by papers in this Series. After my election as WHO Regional Director for the Eastern Mediterranean in January, 2012, my first task was to work closely with WHO member states to agree on an agenda to address these challenges. A series of high-level consultations was held with countries and experts, after a process of objective analysis of the health situation in the countries of the region. It is a region of great diversity. Although many countries, both Arab and non-Arab, have made great gains and have built extensive modern networks of health infrastructure with wide deployment of medical technologies, these gains have not been shared across and within countries. Many of the challenges cut across the health sector and are shared by all countries.

graphic file with name fx1_lrg.jpg

© 2014 Lynsey Addario/VII/Corbis

In October, 2012, health ministers of the region agreed on five key priority areas—highly relevant to all countries—and on strategic directions for public health action to tackle them.1, 2 The priority areas were aligned with the five categories for priority setting that were endorsed by all WHO Member States during the World Health Assembly in May, 2012. Although these directions were intended to guide the work of WHO, their focus and nature make them applicable for a much broader range of stakeholders and partners.

One of the five priorities is strengthening of health systems. Accelerating progress towards universal health coverage by reforming health systems is top priority for WHO in the region. The aim is to ensure access for all people to quality health services without risk of financial hardship. This is a difficult challenge considering the current low levels of prepayment schemes and high out-of-pocket health expenditures in many countries. With support from WHO, and working closely with the World Bank and other partners, countries are beginning to develop a vision, evidence-based strategies, and road maps to move toward universal health coverage. Some countries have started to plan comprehensive reforms, including in health financing, adopting a multisectoral approach.

Another priority is the unfinished agenda of communicable diseases. Despite commendable progress in past decades in reducing the burden of these diseases, important challenges remain and new ones continue to emerge. The coverage and quality of immunisation programmes vary. Viral hepatitis and malaria are major health problems in some countries. The region has the fastest rate of increase among WHO regions in the number of HIV infections and the lowest coverage with antiretroviral therapy. It also has two of the world's three remaining pockets of polio. Recent outbreaks in countries that had been free of polio for many years represent a major impediment to global eradication efforts, and led ministers of health to declare polio a regional emergency and mount a comprehensive response.3 New infections, such as the Middle East respiratory syndrome, also continue to emerge. Although the 2005 International Health Regulations provide a framework for countries to respond to acute public health threats, countries need to do more to meet the requirements set by the World Health Assembly for achieving the core capacities for surveillance and response by June, 2014, at the latest.4

A third priority is maternal and child health; 899 000 children younger than 5 years and 39 000 mothers needlessly die each year in the region from avoidable causes. At the present rate of action, the region as a whole will not be able to achieve Millennium Development Goals 4 and 5. A regional response, the Dubai Declaration for Saving the Lives of Mothers and Children,5 has been launched, and national acceleration plans are being implemented in high-burden countries, which include seven Arab countries.

Non-communicable diseases are also a crucial challenge, particularly cardiovascular diseases, cancers, and diabetes—the burden of each continues to escalate. In some countries, up to 40% of those dying from non-communicable diseases are aged younger than 60 years. The response of countries to the very clear road map for addressing non-communicable diseases outlined in the global strategy6 and the Political Declaration of the United Nations General Assembly7 of September, 2011, is, so far, inadequate. However, countries have adopted a regional framework for action specifying commitments to implement strategic interventions in governance, prevention of risk factors, surveillance, and health care.8 Some progress is being made but gaps in action remain.

The fifth priority is emergency preparedness and response. Protracted emergencies seem almost to have become a way of life in some parts of the region, and more than half of the countries are currently facing either acute or chronic crises. The major source of emergencies is civil unrest and violent conflict. The consequences are clear in the expanding humanitarian crisis in Syria and its neighbours, with rising numbers of people displaced. Health systems in all countries affected are facing major difficulties in coping with the demands. Collective action and solidarity are needed to deliver health services to refugees and host communities, and to increase the resilience of countries to emergencies and ensure effective public health responses during crises.

Much work is still ahead of us in each of these five areas. Health goals in the Arab world will only be realised through the building of strong health systems, solid commitment to health promotion, and ensuring that health is considered in all government policies. Solidarity among countries is of crucial importance. The contribution of high-income countries in the region to achieve better health in low-income countries needs to be scaled up.

Acknowledgments

I declare that I have no conflicts of interest.

References


Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES